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HOW TO ASSESS THE EFFECTS OF PHYSIOTHERAPY
A critical review of the methodology with special attention to outcome parameters
Lex Bouter, Sjef van der Linden and Bart Koes
Department of Epidemiology and Health Care Research, University of Limburg, P.O. Box
616, 6200 MD Maastricht, the Netherlands.
For most patients physiotherapeutic treatment aims at reducing pain or restoring
function. In addition to this, physiotherapy often tries to prevent new episodes of pain
or dysfunction. For patients, for clinicians who consider a physiotherapeutic treatment,
and of course also for the physiotherapists themselves, the crucial question is whether
the intervention will be effective in terms of these goals. Usually there are several
options for intervention, physiotherapeutic or otherwise, between which a choice has to
be made. For clinical decisions the central question is whether the physiotherapeutic
treatment at issue will be better than doing nothing (no intervention) or giving another
treatment.
The central thesis of this article is that randomized clinical trials (RCTs) offer
the best opportunity to get valid (lack of systematic error) and precise (lack of random
error) knowledge about the efficacy of physiotherapeutic interventions. We will limit
ourselves to the case of a single RCT; methods to summarize the results of a number of
trials on the same topic are discussed elsewhere in this volume (Bouter and Ter Riet
1990). Another limitation is that we shall ignore ideas about possible mechanisms of
effect and outcomes that are not very closely linked to the relevant clinical phenomena
(pain and dysfunction). This article begins by explaining the reasons for prefering RCTs
for the study of efficacy, before proceeding to formulate some methodological
guidelines, with special attention to the choice of outcome parameters. In conclusion,
some future priorities for the study of efficacy of physiotherapeutic interventions will
be proposed.
Why a randomized clinical trial?
Efficacy deals with the specific effects of the physiotherapeutic treatment at
issue. Any difference between initial state (baseline) and post-treatment state might be
a consequence of the treatment, but of many other factors as well. For instance,
spontaneous changes due to the natural history of the disease may influence the observed
effect (for better or for worse) in the absence of any specific therapeutic effect of
the intervention. Furthermore, a number of prognostic factors can have a large impact on
the observed effect (e.g. age, sex, aspects of life style, duration and stage of the
disorder, and treatment in the recent past). Imbalance for prognostic factors (between
the groups to be compared) can already be present at the start of the study. But other
factors (e.g. compliance and co-interventions such as analgetic (self-)medication) can
contribute to the observed effect as well.
Traditional methods to study efficacy, like case reports, case seriea, secondary
analyses of registration data and comparison to non-randomized control groups, are
unable to distinguish sufficiently between an observed effect and the specific effect of
the treatment at issue. Consequently, efficacy is usually overestimated by these study
designs (Sacks et al 1982, Miettinen 1983). The basic design for a valid assessment of
the specific effects consists of a comparison between an experimental and a control
group which are formed by random allocation. The control group should have the same
distribution of prognostic factors at baseline as the experimental group, and should be
given the same treatment except for the physiotherapeutic intervention at issue.
Depending on the exact question the study tries to answer, the control group will be
exposed to another intervention (physiotherapeutic or otherwise), a placebo treatment or
no intervention.
The most powerful tool to attain comparability at baseline is randomization. Because
every eligible patient has an equal (usually 50%) chance of being assigned to each
group, randomization prevents bias due to preferences (of patients or physiotherapists)
that might systematically assign the intervention at issue to patients with good (or
bad) prognostic factors (Miettinen 1983). However, imbalance at baseline might still
arise by chance, especially when the size of the groups is small. Therefore, even in a
randomized study the prognostic comparability at baseline should always be evaluated
carefully.
Individual preferences (of patients and of physiotherapists) might also lead to
incomparability later on in the study (e.g. through incomparability of co-
interventions) or to bias in the measurement of the outcome. The latter can constitute a
severe problem, especially for effect parameters that involve a subjective judgement and
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are consequently difficult to standardize. Blinding can prevent these sources of bias.
The central idea is that neither the patient nor the physiotherapist know whether the
patient is in the intervention or in the control group. The best (but not the only) way
to ensure blinding consists of giving the control group a placebo intervention. While
this is relatively easy to perform in drug research, it is often not feasible in
physiotherapeutic studies (but it can be done sometimes, for example by giving ultra
sound, electro or laser therapy with a zero output level).
Methodological guidelines 
A full description of all methodological considerations in designing, conducting and
analyzing an RCT would be outside the scope of this article. Some outstanding textbooks
are currently available for the reader interested in these topics (Pocock 1983, Meinert
1986). Practical rules for assessing the relevance and quality of an RCT have been
developed by Sackett et al (1985). This section will be restricted to the choice of
patients, interventions and effect parameters, and to the difference between clinical
and statistical significance.
The source of the patients (primary care, in- or out-patient clinic) and all
inclusion and exclusion criteria should be stated explicitly. The resulting study
population must be similar to the group of patients outside the study for whom one would
be willing to prescribe the physiotherapeutic intervention involved. This criterium is
fundamentally different from that of representativeness: only comparability for
prognostically relevant factors matters. Another important point is the choice and the
operationalization of the treatment(s). It should always be kept in mind that the skill
of the physiotherapist might influence the specific effect of the treatment to a large
extent. Moreover, the intervention should be matched to the spectrum of patients one
wants to apply the results of the trial to, and to the setting in which they will
usually be treated. For instance, it is not very informative to know the efficacy of a
treatment that can only be given in a specialized clinic for a clinical condition that
is usually encountered in a primary care setting.
The choice of the outcome parameters is of the utmost importance. These should
always be designed to answer the central questions of the study, which will often be
focussed on pain and/or aspects of functional capacity. Therefore, in
physiotherapeutical trials so-called 'hard' measures (e.g. paraspinal EMG activity,
range of motion, X-rays) are of limited relevance, and thus 'soft' outcomes like ratings
on scales for pain and functional status will often be more appropriate. Because
answering the items of these checklists or questionaires will involve a subjective
judgement, blinding of (at least) the patient here becomes very important. In addition,
the quality and appropriateness of the instruments used should be evaluated very
carefully. Recently, criteria for this have been formulated by several authors
(Feinstein 1987, Kirshner & Guyatt 1983, Guyatt et al 1987, Deyo 1988). The main
desiderata for these outcome scales are precision, validity, and responsiveness to
change.
Precision indicates the (relative) absence of random measurement error. Because
imprecision can have a number of different sources, it is important to consider several
aspects separately: test-retest reproducibility, inter- and intra-observer variability
and internal consistency (Deyo 1988). The latter reflects how well the items of the
scale correlate with each other. Validity deals with the question whether the instrument
indeed measures what it is supposed to measure (i.e. lack of systematic measurement
error). Unfortunately for phenomena like pain or functional capacity, a 'gold standard'
is typically lacking. Therefore, usually a construct validation is performed, that is
studying whether the scores on an instrument correlate in the expected manner with those
on other (already established) related instruments. Another proxy-measure of (criterium)
validity consists of content validity, which deals with the question whether the items
of the scale reasonably reflect what would have been expected theoretically.
Of course the most important desideratum of an effect measure in a trial is its
responsiveness to subtle but clinically important changes over time. Surprisingly, most
attention is usually given to scale performance at one moment in time for discriminating
among groups of patients. For use in trials, detection of changes over time for the
Individual patient is much more important, implying that item selection should be
focused on items amenable to change (deleting unresponsive items). The crucial aspect of
( construct) validity now becomes the correlation between changes in scores on the
instrument and changes on relevant external measures over time. Several authors (Deyo
1988, Guyatt et al 1987) provide methods to assess the responsiveness of an outcome
scale and give examples relevant to physiotherapeutic trials.
Knowledge of the test characteristics (precision, validity and responsiveness to
change) of outcome measures in physiotherapeutic trials is very important and decisive
for the statistical power of the trial (that is the chance that an existing clinically
relevant effect will be detected). Unfortunately, this knowledge is often not yet
available and it will usually not be feasible to develop and apply an outcome measure in
the same study. Therefore, research on test characteristics of already existing
instruments and the development of new ones where necessary deserve a high priority.
When interpreting the results of an RCT, the main issue should be whether the
findings can be considered to be of clinical relevance. This will be the case when the
results will influence the choice of treatment for patients belonging to the group at
issue. Statistical significance, as opposed to clinical significance, merely informs us
about the precision of the study and not about the validity and its relevance. More
precisely, the statistical significance is nothing more than a statement about the
likelihood that the study results are due to chance alone. When the sample size of the
study is large enough, irrelevant differences can already be highly significant.
Conversely, when the population is small, even large differences may not reach
statistical significance (Miettinen 1985). For 'negative' studies one should always
wonder whether the study was large enough to detect an existing difference of clinical
importance. The mathematics of this issue are called power or sample-size calculations
for which formulas are provided in most textbooks on RCTs (Pocock 1983, Meinert 1986).
Feasibility of RCTs 
RCTs offer the best possibilities to assess the efficacy of physiotherapeutic
treatment, but their validity and precision are by no means perfect by definition and
there are other serious drawbacks. For instance, trials are costly and time consuming
and require a strict organization that is often not easy to implement in
physiotherapeutic practise. Close cooperation between physiotherapists and researchers
at all levels of designing, conducting and analyzing an RCT is of the utmost importance.
Recently we conducted a large multicenter trial on the efficacy of some treatment
modalities for back and neck pain of which the design and the first results are
described elsewhere in this volume (Koes et al 1990).
There are also a number of emotional objections against RCTs. Health care
professionals (e.g. physiotherapists) often are not willing to admit doubts about
efficacy and sometimes resist 'coinflipping' randomization in order to decide which
treatment their patients will receive. Especially, control treatments consisting of a
placebo are often considered unethical. On the other hand, the practise of prescribing
treatments of doubtful efficacy can be considered to be unethical as well. Of course,
informed consent has always to be sought very carefully, and the use of placebo
treatment will not be easy to justify for severe conditions for which a generally
accepted standard treatment is already available.
Information about the efficacy of already available interventions should be the
central criterion of guidance in the choice of therapy. Although RCTs are certainly
feasible and have been performed for a number of physiotherapeutic treatments, their
validity is still often suboptimal. Especially the development of responsive effect
parameters in the domains of pain and dysfunction deserve a high priority in the near
future. For the further development of physiotherapy RCTs seem to be able to play a very
important role.
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